STOCKHOLM, Sweden I June 28, 2025 I Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® ...

DOYLESTOWN, PA, USA I June 27, 2025 I Metabolics Pharma (“Metabolics”), a privately held, Doylestown-based, clinical-stage biopharmaceutical company ...

NEW YORK, NY, USA I June 26, 2025 I Pfizer Inc. (NYSE: PFE)today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating ...

SEATTLE, WA, USA I June 27, 2025 I Omeros Corporation (Nasdaq: OMER) today announced the recent submission of a Marketing Authorization Application (MAA) to ...

SAN FRANCISCO, CA, USA and SUZHOU, China I June 27, 2025 I Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical ...

Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity ...

TOKYO, Japan I June 27, 2025 I PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting ...

SHANGHAI, China I June 27, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned ...

ATLANTA, GA, USA I June 27, 2025 I UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety and efficacy of ...

LEIDEN, The Netherlands & CAMBRIDGE, MA, USA I June 26, 2025 I ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through ...

First-in-human trial uses the A2 Bio proprietary logic-gated Tmod™ technology platform for precision cell therapies providing selective killing of tumor cells while protecting normal cells AGOURA ...

Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...